2017
DOI: 10.1007/s10549-017-4144-5
|View full text |Cite
|
Sign up to set email alerts
|

A polygenic risk score for breast cancer risk in a Taiwanese population

Abstract: Our data identified a genetic risk predictor of breast cancer in Taiwanese population and suggest that risk models including PRS and clinical risk factors are useful in discriminating women at high risk of breast cancer from those at low risk.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
41
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 36 publications
(45 citation statements)
references
References 36 publications
3
41
1
Order By: Relevance
“…The largest number of studies (n ¼ 14) came from the United States (54)(55)(56)(57)(58)(59)(60)(61)(62)(63)(64)(65)(66)(67). 13 studies evaluated risk prediction models among Caucasian or European populations (23, 24, 54-57, 59, 61-64, 68, 69), eight in Asian populations (53,67,(70)(71)(72)(73)(74)(75), three within mixed populations (58,60,65), one among Australians (76), another among African Americans and Hispanics (66). Sample sizes ranged from 324 to 37,033 women.…”
Section: Statistical Analysesmentioning
confidence: 99%
See 4 more Smart Citations
“…The largest number of studies (n ¼ 14) came from the United States (54)(55)(56)(57)(58)(59)(60)(61)(62)(63)(64)(65)(66)(67). 13 studies evaluated risk prediction models among Caucasian or European populations (23, 24, 54-57, 59, 61-64, 68, 69), eight in Asian populations (53,67,(70)(71)(72)(73)(74)(75), three within mixed populations (58,60,65), one among Australians (76), another among African Americans and Hispanics (66). Sample sizes ranged from 324 to 37,033 women.…”
Section: Statistical Analysesmentioning
confidence: 99%
“…Most studies evaluated the risk prediction models in the general population (24, 53, 55-58, 60, 61, 63, 64, 66-68, 70, 71, 73-76) while others specifically studied non-BRCA mutation carriers (54,62,69), post-menopausal (23,59,65,72) or pre-menopausal women (72). Most studies included only patients with invasive breast cancer as case participants (23, 53, 56-61, 63, 64, 66-70, 73, 74, 76), while six included invasive or in situ breast cancer patients (24,54,55,62,71,75) and two focused on estrogen receptor (ER)-positive patients with breast cancer (65,72).…”
Section: Statistical Analysesmentioning
confidence: 99%
See 3 more Smart Citations